Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL5129 Target Snapshot

Phosphodiesterase 3B · SINGLE PROTEIN · Bos taurus

106Compounds
17Assays
4Approved Drugs
83.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt E1BN64. Use UniProt E1BN64 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt E1BN64 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Phosphodiesterase 3B as ChEMBL target CHEMBL5129, mapped to UniProt E1BN64. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Phosphodiesterase 3B
SINGLE PROTEIN · Bos taurus
As of 2026-09-13
ChEMBL target ID
CHEMBL5129
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
E1BN64
Phosphodiesterase
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Phosphodiesterase 3B is the right protein anchor across sources, using UniProt E1BN64 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelPhosphodiesterase
UniProt AccessionE1BN64
Component TypeProtein
Sequence Length1115 aa

Phosphodiesterase

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Phosphodiesterase 3B, mapped to UniProt E1BN64. ChEMBL maps the protein component as Phosphodiesterase. Sequence length is 1115 aa.

Mapped IDE1BN64
Review namePhosphodiesterase 3B
OrganismBos taurus
Clinical Profile

Clinical Phase Distribution

4
Approved
1
Phase II
Assay Mix

Activity Type Distribution

IC5082.0
KI1.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL103976 8.3 IC50 5.0 Preclinical
CHEMBL319217 7.3 IC50 50.0 Preclinical
CHEMBL395336 7.0 IC50 100.0 Preclinical
CHEMBL304389 6.0 IC50 1000.0 Preclinical
CHEMBL189 6.0 IC50 1000.0 Approved
CHEMBL102807 5.52 IC50 3000.0 Preclinical
CHEMBL308249 5.46 IC50 3500.0 Preclinical
CHEMBL306666 5.22 IC50 6000.0 Preclinical
CHEMBL431377 5.16 IC50 7000.0 Preclinical
CHEMBL138658 5.04 IC50 9200.0 Preclinical
Distribution

pChEMBL Value Distribution

6
5.0
1
5.5
2
6.0
0
6.5
2
7.0
0
7.5
1
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

MILRINONE
CHEMBL189
Approved 1987
Assay Landscape

Assay Landscape

17
Total Assays
57
Tested Compounds
2
Assay Types
Binding — 16 assays, 57 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 16 57 4.8
Functional — 1 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine